G protein-coupled receptor dimerization: Function and ligand pharmacology

Molecular Pharmacology

Volumn 66, Issue 1, 2004, Pages 1-7

  Milligan, Graeme ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ARRESTIN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DIMER; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; ISOPRENALINE; LIGAND; OPIATE RECEPTOR; OXYMETAZOLINE; VALSARTAN;

BINDING AFFINITY; BIOSYNTHESIS; COMPLEX FORMATION; DIMERIZATION; DRUG DESIGN; DRUG RECEPTOR BINDING; FLUORESCENCE RESONANCE ENERGY TRANSFER; HORMONE RECEPTOR INTERACTION; HUMAN; INTERNALIZATION; LIGAND BINDING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; SHORT SURVEY;

ANIMALS; DIMERIZATION; HUMANS; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 3042663287     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.000497.     Document Type: Short Survey

References (84)

1. Angers S, Salahpour A, and Bouvier M (2002) Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev P harmacol Toxicol 42:409-435.
2. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, and Bouvier M (2000) Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 97:3684-3689.
3. Armstrong D and Strange PG (2001) Dopamine D2 receptor dimer formation: evidence from ligand binding. J Biol Chem 276:22621-22629.
4. Ayoub MA, Couturier C, Lucas-Meunier E, Angers S, Fossier P, Bouvier M, and Jockers R (2002) Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem 277:21522-21528.
5. Babcock GJ, Farzan M, and Sodroski J (2003) Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J Biol Chem 278:3378-3385.
6. Barki-Harrington L, Luttrell LM, and Rockman HA (2003) Dual inhibition of beta-adrenergic and angiotonsin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation 108:1611-1618.
7. Baneres JL and Parello J (2003) Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 329:815-829.
8. Berglund MM, Schober DA, Esterman MA, and Gehlert DR (2003) Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. J Pharmacol Exp Ther 307:1120-1126.
9. Carrillo JJ, Pediani J, and Milligan G (2003) Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. J Biol Chem 278:42578-42587.
10. Chabre M, Cone R, and Saibil H (2003) Biophysics: is rhodopsin dimeric in native retinal rods? Nature (Lond) 426:30-31.
11. Cheng ZJ and Miller LJ (2001) Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J Biol Chem 276:48040-48047.
12. 3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors. Biochem J 343:231-239.
13. Cordeaux Y and Hill SJ (2002) Mechanisms of cross-talk between G-protein-coupled receptors. Neurosignals 11:45-57.
14. Cornea A, Janovick JA, Maya-Nunez G, and Conn PM (2001) Gonadotropin-releasing hormone receptor microaggregation. Rate monitored by fluorescence resonance energy transfer. J Biol Chem 276:2153-2158.
15. Cvejic S and Devi LA (1997) Dimerization of the delta opioid receptor: implication for a role in receptor internalisation. J Biol Chem 272:26959-26964.
16. Devi LA (2001) Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol Sci 22:532-537.
17. Dinger MC, Bader JE, Kobor AD, Kretzschmar AK, and Beck-Sickinger AG (2003) Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J Biol Chem 278:10562-10571.
18. Ferre S, Karcz-Kubicha M, Hope BT, Popoli P, Burgueno J, Gutierrez MA, Casado V, Fuxe K, Goldberg SR, Lluis C, et al. (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci USA 99:11940-11945.
19. Filizola M, Olmea O, and Weinstein H (2002) Prediction of heterodimerization interfaces of G-protein coupled receptors with a new subtractive correlated mutation method. Protein Eng 15:881-885.
20. Floyd DH, Geva A, Bruinsma SP, Overton MC, Blumer KJ, and Baranski TJ (2003) C5a receptor oligomerization. II. Fluorescence resonance energy transfer studies of a human G protein-coupled receptor expressed in yeast. J Biol Chem 278: 35354-35361.
21. Fredriksson R, Lagerstrom MC, Lundin LG, and Schioth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256-1272.
22. George SR, Ng GY, Lee SP, Fan T, Varghese G, Wang C, Deber CM, Seeman P, and O'Dowd BF (2003) Blockade of G protein-coupled receptors and the dopamine transporter by a transmembrane domain peptide: novel strategy for functional inhibition of membrane proteins in vivo. J Pharmacol Exp Ther 307:481-489.
23. George SR, O'Dowd BF, and Lee SP (2002) G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 1:808-820.
24. Guo W, Shi L, and Javitch JA (2003) The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J Biol Chem 278:4385-4388.
25. Hakak Y, Shrestha D, Goegel MC, Behan DP, and Chalmers DT (2003) Global analysis of G-protein-coupled receptor signaling in human tissues. FEBS Lett 550:11-17.
26. Han M, Gurevich VV, Vishnivetskiy SA, Sigler PB, and Schubert C (2001) Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane translocation. Structure 9:869-880.
27. Hanyaloglu AC, Seeber RM, Kohout TA, Lefkowitz RJ, and Eidne KA (2002) Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2. J Biol Chem 277:50422-50430.
28. He L, Fong J, von Zastrow M, and Whistler JL (2002) Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108:271-282.
29. Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, and Bouvier M (1996) A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271:16384-16392.
30. Issafras H, Angers S, Bulenger S, Blanpain C, Parmentier M, Labbe-Jullie C, Bouvier M, and Marullo S (2002) Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J Biol Chem 277:34666-24673.
31. Jordan BA and Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature (Lond) 399:697-700.
32. Jordan BA, Cvejic S, and Devi LA (2000) Opioids and their complicated receptor complexes. Neuropsychopharmacology 23:S5-S18.
33. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, and Devi LA (2001) Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci USA 98:343-348.
34. Karpa KD, Lin R, Kabbani N, and Levenson R (2000) The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. Mol Pharmacol 58:677-683.
35. Kroeger KM, Hanyaloglu AC, Seeber RM, Miles LE, and Eidne KA (2001) Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer. J Biol Chem 276:12736-12743.
36. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, and Morikawa K (2000) Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature (Lond) 407:971-977.
37. Latif R, Graves P, and Davies TF (2001) Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. J Biol Chem 277:45059-45067.
38. Lee C, Ji I, Ryu K, Song Y, Conn PM, and Ji TH (2002) Two defective heterozygous luteinizing hormone receptors can rescue hormone action. J Biol Chem 277:15795-15800.
39. Lee SP, O'Dowd BF, and George SR (2003a) Homo- and hetero-oligomerization of G protein-coupled receptors. Life Sci 74:173-180.
40. Lee SP, O'Dowd BF, Ng GY, Varghese G, Akil H, Mansour A, Nguyen T, and George SR (2000) Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Mol Pharmacol 58:120-128.
41. Lee SP, O'Dowd BF, Rajaram RD, Nguyen T, and George SR (2003b) D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. Biochemistry 42:11023-11031.
42. Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, and Engel A (2003) Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 278:21655-21662.
43. 11 α requires both β/γ interactions and an aromatic group 4 amino acid from the C-terminus of the G protein. J Biol Chem 277:25707-25714.
44. McVey M, Ramsay D, Kellett E, Rees S, Wilson S, Pope AJ, and Milligan G (2001) Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer: the human δ opioid receptor displays constitutive oligomerization at the cell surface which is not regulated by receptor occupancy. J Biol Chem 276:14092-14099.
45. Maggio R, Scarselli M, Novi F, Millan MJ, and Corsini GU (2003) Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole. J Neurochem 87:631-641.
46. Malnic B, Godfrey PA, and Buck LB (2004) The human olfactory receptor gene family. Proc Natl Acad Sci USA 101:2584-2589.
47. Marshall FH (2001) Heterodimerization of G-protein-coupled receptors in the CNS. Curr Opin Pharmacol 1:40-44.
48. Marshall FH, Jones KA, Kaupmann K, and Bettler B (1999) GABAB receptors - the first 7TM heterodimers. Trends Pharmacol Sci 20:396-399.
49. Matsunami H and Amrein H (2004) Taste perception: how to make a gourmet mouse. Curr Biol 14:118-120.
50. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, Fernandez S, Martin de Ana A, Jones DR, Toran JL, and Martinez-A C (2001) Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO (Eur Mol Biol Organ) J 20:2497-2507.
51. Mercier JF, Salahpour A, Angers S, Breit A, and Bouvier M (2002) Quantitative assessment of β1- and β2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277:44925-44931.
52. Milligan G (2004) Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors. Eur J Pharm Sci 21:397-405.
53. Milligan G, Lopez-Gimenez JF, Wilson S, and Carrillo J (2004) Selectivity in the oligomerisation of G protein-coupled receptors. Semin Cell Develop Biol, in press.
54. Milligan G, Ramsay D, Pascal G, and Carrillo JJ (2003) GPCR dimerisation. Life Sci 74:181-188.
55. Mohler H and Fritschy JM (1999) GABAB receptors make it to the top-as dimers. Trends Pharmacol Sci 20:87-89.
56. Ng GY, O'Dowd BF, Lee SP, Chung HT, Brann MR, Seeman P, and George SR (1996) Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun 227:200-204.
57. Nimchinsky EA, Hof PR, Janssen WG, Morrison JH, and Schmauss C (1997) Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J Biol Chem 272:29229-29237.
58. Overton MC and Blumer KJ (2000) G-protein-coupled receptors function as oligomers in vivo. Curr Biol 10:341-344.
59. Overton MC, Chinault SL, and Blumer KJ (2003) Oligomerization, biogenesis and signaling is promoted by a glycophorin A-like dimerization motif in transmembrane domain 1 of a yeast G protein-coupled receptor. J Biol Chem 278:49369-49377.
60. Pan YX, Bolan E, and Pastrnak GW (2002) Dimerization or morphine and orphanin/nociceptin receptors: generation of a novel opioid receptor subtype. Biochem Biophys Res Commun 297:659-663.
61. Pfeiffer M, Kirscht S, Stumm R, Koch T, Wu D, Laugsch M, Schroder H, Hollt V, and Schulz S (2003) Heterodimerization of substance P and μ-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 278:51630-51637.
62. Ramsay D, Kellett E, McVey M, Rees S, and Milligan G (2002) Homo- and heterooligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem J 365:429-440.
63. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, and Patel YC (2000a) Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science (Wash DC) 288:154-157.
64. Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, and Patel YC (2000b) Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem 275:7862-7869.
65. Rodriguez-Frade JM, Del Real G, Serrano A, Hernanz-Falcon P, Soriano SF, Vila-Coro AJ, De Ana AM, Lucas P, Prieto I, Martinez-AC, and Mellado M (2004) Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor. EMBO (Eur Mol Biol Organ) J 23:66-76.
66. Rodriguez-Frade JM, Vila-Coro AJ, de Ana AM, Albar JP, Martinez-A C and Mellado M (1999) The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc Natl Acad Sci USA 96:3628-3633.
67. Salim K, Fenton T, Bacha J, Urien-Rodriguez H, Bonnert T, Skynner HA, Watts E, Kerby J, Heald A, Beer M, et al. (2002) Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. J Biol Chem 277:15482-15485.
68. Shenoy SK and Lefkowitz RJ (2003) Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375:503-515.
69. Soyer OS, Dimmic MW, Neubig RR, and Goldstein RA (2003) Dimerization in aminergic G-protein-coupled receptors: application of a hidden-site class model of evolution. Biochemistry 42:14522-14531.
70. 1b-adrenergic receptor subtypes. J Biol Chem 278:40239-40251.
71. Tao YX, Johnson NB, and Segaloff DL (2004) Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J Biol Chem 279: 5904-5914.
72. Terrillon S, Barberis C, and Bouvier M (2004) Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns. Proc Natl Acad Sci USA 101:1548-1553.
73. Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub MA, Taulan M, Jockers R, Barberis C, and Bouvier M (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol Endocrinol 17:677-691.
74. Trettel F, Di Bartolomeo S, Lauro C, Catalano M, Ciotti MT, and Limatola C (2003) Ligand-independent CXCR2 dimerization. J Biol Chem 278:40980-40988.
75. Tsao PI and von Zastrow M (2000) Type-specific sorting of G protein-coupled receptors after endocytosis. J Biol Chem 275:11130-11140.
76. Uberti MA, Hall RA, and Minneman KP (2003) Subtype-specific dimerization of α1-adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 64:1379-1390.
77. Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT, Brown A, Rodriguez SS, Weller JR, Wright AC, et al. (2003) The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA 100:4903-4908.
78. Vila-Coro AJ, Mellado M, Martin de Ana A, Lucas P, del Real G, Martinez-AC, and Rodriguez-Frade JM (2000) HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc Natl Acad Sci USA 97:3388-3393.
79. Vila-Coro AJ, Rodriguez-Frade JM, Martin De Ana A, Moreno-Ortiz MC, Martinez-AC, and Mellado M (1999) The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J 13:1699-1710.
80. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, and Marshall FH (1998) Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature (Lond) 396:679-682.
81. Woolf PJ and Linderman JJ (2003) Self organization of membrane proteins via dimerization. Biophys Chem 104:217-227.
82. Yesilaltay A and Jenness DD (2000) Homo-oligomeric complexes of the yeast alpha-factor pheromone receptor are functional units of endocytosis. Mol Biol Cell 11: 2873-2884.
83. Zhao GQ, Zhang Y, Hoon MA, Chandrashekar J, Erlenbach I, Ryba NJ, and Zuker CS (2003) The receptors for mammalian sweet and umami taste. Cell 115:255-266.
84. Yoshioka K, Saitoh O, and Nakata H (2001) Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci USA 98:7617-7622.